Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M McCall

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Current Topics in Medicinal Chemistry|September 27, 2005
Risk reduction in drug discovery and developmentMartin Mackay, Stephen D A Street, John M McCall
Bioorganic & Medicinal Chemistry|March 19, 2013
VBP15: preclinical characterization of a novel anti-inflammatory delta 9,11 steroidErica K M Reeves, Eric P Hoffman, Kanneboyina Nagaraju, et al.
Physical Medicine and Rehabilitation Clinics of North America|November 10, 2012
Novel approaches to corticosteroid treatment in Duchenne muscular dystrophyEric P Hoffman, Erica Reeves, Jesse Damsker, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 5, 2016
VBP15, a novel dissociative steroid compound, reduces NFκB-induced expression of inflammatory cytokines in vitro and symptoms of murine trinitrobenzene sulfonic acid-induced colitisJesse M Damsker, Laurie S Conklin, Soheil Sadri, et al.
Steroids|March 11, 2018
Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomesEric P Hoffman, Valerie Riddle, Maxime A Siegler, et al.
Cellular and Molecular Neurobiology|November 14, 2014
VBP15, a novel anti-inflammatory, is effective at reducing the severity of murine experimental autoimmune encephalomyelitisBlythe C Dillingham, Susan M Knoblach, Gina M Many, et al.
Plos One|May 14, 2013
VBP15, a glucocorticoid analogue, is effective at reducing allergic lung inflammation in miceJesse M Damsker, Blythe C Dillingham, Mary C Rose, et al.
Steroids|November 20, 2025
Exposure-response of serum biomarkers to vamorolone, a dissociative corticosteroidal anti-inflammatory drug, in 4- to <7-year childrenSwati Mummidivarpu, Utkarsh J Dang, Michael Ziemba, et al.
EMBO Molecular Medicine|September 10, 2013
VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effectsChristopher R Heier, Jesse M Damsker, Qing Yu, et al.
Neurology|August 28, 2019
Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle functionEric P Hoffman, Benjamin D Schwartz, Laurel J Mengle-Gaw, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Topics in Medicinal Chemistry|September 27, 2005
Risk reduction in drug discovery and developmentMartin Mackay, Stephen D A Street, John M McCall
Bioorganic & Medicinal Chemistry|March 19, 2013
VBP15: preclinical characterization of a novel anti-inflammatory delta 9,11 steroidErica K M Reeves, Eric P Hoffman, Kanneboyina Nagaraju, et al.
Physical Medicine and Rehabilitation Clinics of North America|November 10, 2012
Novel approaches to corticosteroid treatment in Duchenne muscular dystrophyEric P Hoffman, Erica Reeves, Jesse Damsker, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 5, 2016
VBP15, a novel dissociative steroid compound, reduces NFκB-induced expression of inflammatory cytokines in vitro and symptoms of murine trinitrobenzene sulfonic acid-induced colitisJesse M Damsker, Laurie S Conklin, Soheil Sadri, et al.
Steroids|March 11, 2018
Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomesEric P Hoffman, Valerie Riddle, Maxime A Siegler, et al.
Cellular and Molecular Neurobiology|November 14, 2014
VBP15, a novel anti-inflammatory, is effective at reducing the severity of murine experimental autoimmune encephalomyelitisBlythe C Dillingham, Susan M Knoblach, Gina M Many, et al.
Plos One|May 14, 2013
VBP15, a glucocorticoid analogue, is effective at reducing allergic lung inflammation in miceJesse M Damsker, Blythe C Dillingham, Mary C Rose, et al.
Steroids|November 20, 2025
Exposure-response of serum biomarkers to vamorolone, a dissociative corticosteroidal anti-inflammatory drug, in 4- to <7-year childrenSwati Mummidivarpu, Utkarsh J Dang, Michael Ziemba, et al.
EMBO Molecular Medicine|September 10, 2013
VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effectsChristopher R Heier, Jesse M Damsker, Qing Yu, et al.
Neurology|August 28, 2019
Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle functionEric P Hoffman, Benjamin D Schwartz, Laurel J Mengle-Gaw, et al.
Pageof 2